May 7, 2013 - MEB closed on Ascension Day

We would like to inform you that the Medicines Evaluation Board (MEB) is closed on Ascension Day, Thursday 9th May, 2013. As a consequence, on Friday, 10th May, there will be only a limited number of employees present on this day. If necessary, you can leave a message on the voicemail or via our contactform.

April 26, 2013 - MEB chairman receives Royal Honour

On Friday morning 26 April – prior to the last Queen’s Day – Prof. Bert Leufkens received a Royal Honour. Prof. Bert Leufkens is professor of pharmaco-epidemiology at the University of Utrecht (UU) and chairman of the Medicines Evaluation Board (MEB).

April 25, 2013 - MEB closed on Queen’s Day

We would like to inform you that the Medicines Evaluation Board (MEB) is closed on Queen’s Day, Tuesday April 30, 2013. As a consequence, on Monday, 29th April, there will be only a limited number of employees present on this day. If necessary, you can leave a message on the voicemail or via our contactform.

April 16, 2013 - New deputy director MEB

Mr. C.A. (Stan) van Belkum has been appointed deputy director and succeeds Rob de Haan, who accepted the role of director of the Health Care Inspectorate (IGZ) as of 18 March 2013.

April 15, 2013 - MEB Day celebrates anniversary: start of registration

Registration for the MEB Day of the Medicines Evaluation Board (MEB) has started. The MEB Day takes place on Wednesday 5 June 2013, in Media Plaza (Jaarbeurs Convention Centre) in Utrecht. This year's theme is ‘50 years of MEB and beyond’. In connection with this festive theme, an interesting programme has been organised.

March 28, 2013 - MEB closed on Easter

Please be informed that the Medicines Evaluation Board (MEB) is closed on Easter, Monday April 1 2013. 

An overview of the days on which the MEB is closed can be found on the contact page.

March 28, 2013 - MEB at the 25th DIA EuroMeeting

The 25^th annual European meeting of the DIA took place in Amsterdam from 4 through 6 March 2013.  A large number of speakers from the Medicines Evaluation Board contributed to the scientific programme.  The annual conference of the Drug Information Association – a global organisation in the field of (bio)pharmaceutical medicines – offers a podium to scientists, policy makers, companies and organisations in the field of medicines in order to discuss important trends and new developments.

March 19, 2013 - Public consultation MEB Strategic Business Plan 2014-2018

The Medicines Evaluation Board (MEB) has made its draft Strategic Business Plan (SBP) 2014 – 2018 open for public consultation until 31 March 2013.

March 18, 2013 - Database Human Medicines and Database Veterinary Medicines temporarily not available

The Database Human Medicines and Database Veterinary Medicines will be temporarily not available tomorrow (Tuesday March 19th) starting 2.00 pm due to maintenance.

Wednesday March 20th everything will be available again.

March 18, 2013 - Electronic submissions: Another step forward

On Tuesday, 12 March, the MEB held a well-attended meeting on the subject of developments concerning electronic submissions. After Rob de Haan opened and explained the background, the following presentations were given to more than 150 participants.

March 4, 2013 - Programme for meeting on 12 March “Developments surrounding electronic submission”

On Tuesday, 12 March the MEB will organise a meeting in the Jaarbeurs Conference Centre (Beatrix building, Jaarbeursplein, 3521 AL Utrecht) about a number of subjects surrounding the electronic submission of authorisation data.

February 19, 2013 - MEB attends 25th annual DIA meeting

The annual Drug Information Association (DIA) congress takes place in the RAI in Amsterdam from 4 March until 6 March 2013. The DIA is a global organisation in the field of innovation, development, regulatory affairs, pharmacovigilance and reimbursement for medicinal products and medical devices. The congress offers scientists, policy-makers, companies and organisations in the area of medicines a stage where they can draw attention to important trends and new developments.

January 30, 2013 - New Members of the EMA Management Board appointed

On 20 December 2012, four new members were appointed to the Management Board of the European Medicines Agency (EMA); all are representatives from the doctor’s and patient’s organisations.

January 24, 2013 - MEB meeting about developments concerning digital submission

On Tuesday, 12 March 2013, from 9.00 a.m. to 12.30 p.m., the Medicines Evaluation Board (MEB) is organising a meeting in the Jaarbeurs Utrecht with the theme ‘New developments concerning digital submission’. During this meeting the Common European Submission Platform (CESP) will be discussed.

January 16, 2013 - MEB in figures: 2012

This past year, the Medicines Evaluation Board (MEB) has processed and concluded a record number of cases. This amounted to a total of more than 25,000 cases.

January 11, 2013 - Departure of MEB member Mulder

MEB member Prof. Gerard Mulder left the Medicines Evaluation Board (MEB) as of 1 January 2013.

January 2, 2013 - Best wishes for the new year!